Brush Buddies Crayola Anticavity Fluoride - Bubble Gum Flavor

Description

The product features a bubble gum flavor, providing a distinct and recognizable taste profile.

Uses and Indications

This drug is indicated for the protection of teeth against cavities. It is designed to help maintain oral health by reducing the risk of dental caries.

Dosage and Administration

Adults and children aged 6 years and older should use the rinse daily after brushing their teeth with toothpaste. Prior to use, it is essential to rinse the mouth thoroughly to remove any residual toothpaste. The bottle should be shaken well before each use.

To administer, twist and remove the cap, then measure 15 ml of the rinse. The patient should rinse or gargle for 30 seconds and then spit out the solution. It is critical to instruct patients not to swallow the rinse. Additionally, patients should refrain from eating or drinking for 30 minutes following the rinsing procedure to ensure optimal effectiveness.

For children under 6 years of age, it is recommended to consult with a dentist or doctor before use. Supervision may be necessary for children to ensure proper administration.

Contraindications

Use is contraindicated in children under 6 years of age; the product should be kept out of their reach. In the event of accidental ingestion beyond the recommended use for rinsing, it is imperative to seek professional medical assistance or contact a Poison Control Center immediately.

Warnings and Precautions

It is imperative to keep this product out of the reach of children under 6 years of age. In the event of accidental ingestion of an amount exceeding that used for rinsing, immediate professional assistance should be sought, or the individual should contact a Poison Control Center without delay.

No specific general precautions or laboratory tests have been identified for this product. However, healthcare professionals should remain vigilant and ensure that patients are aware of the potential risks associated with misuse.

Side Effects

Patients should be aware of the potential risks associated with the use of this product. It is crucial to keep the product out of reach of children under 6 years of age. In the event of accidental ingestion of more than the amount used for rinsing, it is imperative to seek professional help or contact a Poison Control Center immediately.

While specific adverse reactions have not been detailed in clinical trials or postmarketing experiences, the importance of adhering to safety guidelines cannot be overstated to prevent serious outcomes.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Brush Buddies Crayola Anticavity Fluoride - Bubble Gum Flavor (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should be kept out of reach of this product. For children in this age group, it is advised to consult with a dentist or doctor prior to use. For pediatric patients aged 6 years and older, the product is intended for daily use following tooth brushing with toothpaste.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals may consider the absence of data when advising lactating mothers about the use of this medication. Further clinical judgment may be necessary based on individual circumstances.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative to seek professional assistance or contact a Poison Control Center immediately if an individual accidentally swallows more than the recommended amount used for rinsing.

Healthcare professionals should be aware that prompt action is crucial in managing potential overdosage situations. Symptoms may vary depending on the substance involved, and monitoring the patient for any adverse effects is essential.

Management procedures should include a thorough assessment of the patient's condition and the implementation of supportive care as necessary. It is advisable to follow established protocols for overdosage management, which may involve symptomatic treatment and monitoring of vital signs.

In all cases of suspected overdosage, the involvement of poison control experts can provide valuable guidance on the appropriate course of action.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to fully evaluate the nonclinical toxicology profile.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children under 6 years of age to prevent accidental ingestion. It is important to emphasize the potential risks associated with misuse. Instruct patients that if they accidentally swallow more than the amount intended for rinsing, they should seek professional help or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and minimizing the risk of adverse effects.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity.

To ensure optimal preservation, the product must be protected from light exposure. Additionally, it should be kept tightly closed when not in use to prevent contamination and degradation. It is important to discard the product after opening to ensure safety and efficacy.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients to keep the product out of reach of children under 6 years of age. In the event of accidental ingestion beyond the amount used for rinsing, patients should seek professional help or contact a Poison Control Center immediately. It is important for patients not to swallow the rinse and to refrain from eating or drinking for 30 minutes after rinsing. Supervision of children during use is recommended, and consultation with a dentist or doctor is advised for children under 6 years of age.

Drug Information (PDF)

This file contains official product information for Brush Buddies Crayola Anticavity Fluoride - Bubble Gum Flavor, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)